Skip to main content
. Author manuscript; available in PMC: 2014 Nov 24.
Published in final edited form as: Invest New Drugs. 2013 Feb 8;31(5):1142–1150. doi: 10.1007/s10637-013-9932-0

Fig. 4.

Fig. 4

Tumor growth inhibition by calixarenes in the B16F10 melanoma model. a B16F10 tumor growth inhibition by calixarenes PTX008, PTX009, PTX013, and PTX015 (10 mg/kg BID IP for 7 days). b Body weights of the mice during PTX008, PTX009, PTX013, and PTX015 (10 mg/kg BID IP for 7 days) treatment. Data points represent means±SEM (n=10 each group)